Search Results

Sorafenib Evaluation Sample  | 99.89%

APEXBIO TECHNOLOGY LLC

Raf kinases and tyrosine kinases inhibitor Tyrosine Kinase|PDGFR

More Information Supplier Page

×

Sorafenib

Sorafenib 10mM (in 1mL DMSO)  | 99.89%

APEXBIO TECHNOLOGY LLC

Raf kinases and tyrosine kinases inhibitor Tyrosine Kinase|PDGFR

More Information Supplier Page

×

Sorafenib

Y-27632 dihydrochloride 200mg  | 98.29%

APEXBIO TECHNOLOGY LLC

ROCK1 inhibitor TGF-β / Smad Signaling|ROCK

More Information Supplier Page

×

Y-27632 dihydrochloride

Y-27632 dihydrochloride 50mg  | 98.29%

APEXBIO TECHNOLOGY LLC

ROCK1 inhibitor TGF-β / Smad Signaling|ROCK

More Information Supplier Page

×

Y-27632 dihydrochloride

Y-27632 dihydrochloride 10mg  | 98.29%

APEXBIO TECHNOLOGY LLC

ROCK1 inhibitor TGF-β / Smad Signaling|ROCK

More Information Supplier Page

×

Y-27632 dihydrochloride

ABT-263 (Navitoclax) 10mg  | 98.02%

APEXBIO TECHNOLOGY LLC

Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w Apoptosis|Bcl-2 Family

More Information Supplier Page

×

ABT-263 (Navitoclax)

ABT-263 (Navitoclax) 50mg  | 98.02%

APEXBIO TECHNOLOGY LLC

Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w Apoptosis|Bcl-2 Family

More Information Supplier Page

×

ABT-263 (Navitoclax)

ABT-263 (Navitoclax) 100mg  | 98.02%

APEXBIO TECHNOLOGY LLC

Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w Apoptosis|Bcl-2 Family

More Information Supplier Page

×

ABT-263 (Navitoclax)

ABT-263 (Navitoclax) 1g  | 98.02%

APEXBIO TECHNOLOGY LLC

Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w Apoptosis|Bcl-2 Family

More Information Supplier Page

×

ABT-263 (Navitoclax)

Y-27632 dihydrochloride 10mM (in 1mL DMSO)  | 98.29%

APEXBIO TECHNOLOGY LLC

ROCK1 inhibitor TGF-β / Smad Signaling|ROCK

More Information Supplier Page

×

Y-27632 dihydrochloride